JUPITER NEUROSCIENCES INC (JUNS) Stock News

USA - NASDAQ:JUNS - US48208B2034 - Common Stock

1.43 USD

+0.05 (+3.62%)

Last: 10/31/2025, 8:00:02 PM

1.44 USD

+0.01 (+0.7%)

After Hours: 10/31/2025, 8:00:02 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

JUNS Latest News, Press Relases and Analysis

All

Press Releases

7 days ago - By: Jupiter Neurosciences, Inc.

Jupiter Neurosciences Enters into Agreements for up to $20 Million in Flexible Financing

3 months ago - By: Jupiter Neurosciences, Inc.

Jupiter Neurosciences Names NBA Legend Chris Webber as Second Nugevia™ Brand Ambassador

3 months ago - By: Jupiter Neurosciences, Inc.

Jupiter Neurosciences Highlights Critical Advancement of JOTROL™ Over Traditional Resveratrol with Breakthrough Bioavailability and CNS-Targeted Science

4 months ago - By: Benzinga - Mentions: CDNA CLSD WINT OVID ...

12 Health Care Stocks Moving In Thursday's Intraday Session

4 months ago - By: Benzinga - Mentions: CALC KPTI CAPR ATHE ...

12 Health Care Stocks Moving In Friday's Intraday Session

4 months ago - By: Jupiter Neurosciences, Inc.

Jupiter Neurosciences Regains Compliance with Nasdaq Minimum Bid Price Requirement

4 months ago - By: Jupiter Neurosciences, Inc.

Jupiter Neurosciences Showcases Nugevia™ PWR: Mitochondrial Optimization Supplement Designed to Boost Energy, Endurance, and Recovery

4 months ago - By: Jupiter Neurosciences, Inc.

Jupiter Neurosciences Names Golf Legend Annika Sörenstam as First Nugevia™ Brand Ambassador

5 months ago - By: Jupiter Neurosciences, Inc.

Jupiter Neurosciences Launches Nugevia™: A Premium Longevity and Performance Supplement Line Grounded in Clinical Science